CA095568/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2005	1
2006	2
2007	1
2008	1
2009	1
2011	1
2014	1
2015	1
2017	2
2022	0

1

Unmasking the lung cancer epigenome.

Belinsky SA. Belinsky SA. Annu Rev Physiol. 2015;77:453-74. doi: 10.1146/annurev-physiol-021014-072018. Annu Rev Physiol. 2015. PMID: 25668024 Review.

2

DNA methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer.

Belinsky SA, Schiller JH, Stidley CA. Belinsky SA, et al. Nutr Rev. 2008 Aug;66 Suppl 1(Suppl 1):S24-6. doi: 10.1111/j.1753-4887.2008.00061.x. Nutr Rev. 2008. PMID: 18673483 Free PMC article. Review. No abstract available.

3

Gene methylation biomarkers in sputum as a classifier for lung cancer risk.

Leng S, Wu G, Klinge DM, Thomas CL, Casas E, Picchi MA, Stidley CA, Lee SJ, Aisner S, Siegfried JM, Ramalingam S, Khuri FR, Karp DD, Belinsky SA. Leng S, et al. Oncotarget. 2017 Jul 15;8(38):63978-63985. doi: 10.18632/oncotarget.19255. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28969046 Free PMC article.

4

Gene promoter methylation in plasma and sputum increases with lung cancer risk.

Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, Crowell RE, Karp DD, Stidley CA, Picchi MA. Belinsky SA, et al. Clin Cancer Res. 2005 Sep 15;11(18):6505-11. doi: 10.1158/1078-0432.CCR-05-0625. Clin Cancer Res. 2005. PMID: 16166426

5

Gene promoter hypermethylation in mouse lung tumors.

Vuillemenot BR, Hutt JA, Belinsky SA. Vuillemenot BR, et al. Mol Cancer Res. 2006 Apr;4(4):267-73. doi: 10.1158/1541-7786.MCR-05-0218. Mol Cancer Res. 2006. PMID: 16603640

6

Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence.

Belinsky SA, Leng S, Wu G, Thomas CL, Picchi MA, Lee SJ, Aisner S, Ramalingam S, Khuri FR, Karp DD. Belinsky SA, et al. Cancer Prev Res (Phila). 2017 Nov;10(11):635-640. doi: 10.1158/1940-6207.CAPR-17-0177. Epub 2017 Sep 13. Cancer Prev Res (Phila). 2017. PMID: 28904059 Free PMC article.

7

Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model.

Lyon CM, Klinge DM, Do KC, Grimes MJ, Thomas CL, Damiani LA, March TH, Stidley CA, Belinsky SA. Lyon CM, et al. Carcinogenesis. 2009 Dec;30(12):2095-9. doi: 10.1093/carcin/bgp260. Carcinogenesis. 2009. PMID: 19861651 Free PMC article.

8

Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer.

Machida EO, Brock MV, Hooker CM, Nakayama J, Ishida A, Amano J, Picchi MA, Belinsky SA, Herman JG, Taniguchi S, Baylin SB. Machida EO, et al. Cancer Res. 2006 Jun 15;66(12):6210-8. doi: 10.1158/0008-5472.CAN-05-4447. Cancer Res. 2006. PMID: 16778195

9

Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model.

Belinsky SA, Grimes MJ, Picchi MA, Mitchell HD, Stidley CA, Tesfaigzi Y, Channell MM, Liu Y, Casero RA Jr, Baylin SB, Reed MD, Tellez CS, March TH. Belinsky SA, et al. Cancer Res. 2011 Jan 15;71(2):454-62. doi: 10.1158/0008-5472.CAN-10-3184. Epub 2011 Jan 11. Cancer Res. 2011. PMID: 21224363 Free PMC article.

10

GATA2 is epigenetically repressed in human and mouse lung tumors and is not requisite for survival of KRAS mutant lung cancer.

Tessema M, Yingling CM, Snider AM, Do K, Juri DE, Picchi MA, Zhang X, Liu Y, Leng S, Tellez CS, Belinsky SA. Tessema M, et al. J Thorac Oncol. 2014 Jun;9(6):784-93. doi: 10.1097/JTO.0000000000000165. J Thorac Oncol. 2014. PMID: 24807155 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results